Literature DB >> 12938205

RSV-induced bronchiolitis but not upper respiratory tract infection is accompanied by an increased nasal IL-18 response.

Inesz J van Benten1, Cornelis M van Drunen, Laurens P Koopman, Alex KleinJan, Barbara C van Middelkoop, Leon de Waal, Albert D M E Osterhaus, Herman J Neijens, Wytske J Fokkens.   

Abstract

The aim of this study was to investigate potential differences in the local nasal immune response between bronchiolitis and upper respiratory tract infection induced by respiratory syncytial virus (RSV). Nasal brush samples were obtained from 14 infants with RSV bronchiolitis and from 8 infants with RSV upper respiratory tract infection. The samples were taken during infection (acute phase) and 2-4 weeks later (convalescent phase). Cytospin preparations were stained immunohistochemically for T cells, macrophages, and eosinophils. Staining also took place for intercellular adhesion molecule-1 (ICAM-1), T-helper 1 (Th1)-like (interleukin-12 [IL-12], interferon-gamma [IFN-gamma]), Th2-like (IL-4, IL-10), and proinflammatory cytokines (IL-6, IL-8, IL-18). During both RSV-induced bronchiolitis and upper respiratory tract infection, cellular inflammation was observed. This was characterised by an increase in the numbers of nasal macrophages, which tended to be higher in bronchiolitis than in upper respiratory tract infection. Numbers of T lymphocytes and ICAM-1 positive cells increased during both bronchiolitis and upper respiratory tract infection. There were no differences between numbers in the groups. Interestingly, a distinct nasal proinflammatory cytokine response was observed in RSV-induced bronchiolitis. This is characterised by an increase in the number of IL-18 positive cells. This increase is specific for bronchiolitis, as a similar increase could not be detected in RSV-induced upper respiratory tract infection. Numbers of IL-6 and IL-12 positive cells were higher in both bronchiolitis and upper respiratory tract infection, and there were no differences between the groups. By contrast, the number of IL-8, IFN-gamma, IL-4, and IL-10-positive cells remained constant. In conclusion, clear differences were found in nasal immune responses of children with RSV-induced upper respiratory tract infection or bronchiolitis. The induction of a strong IL-18 response was typical for bronchiolitis, as this could not be observed in RSV-induced upper respiratory tract infection, and could explain the eosinophilia that is observed frequently during bronchiolitis. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12938205      PMCID: PMC7166712          DOI: 10.1002/jmv.10482

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  33 in total

1.  Adhesion molecule expression on epithelial cells infected with respiratory syncytial virus.

Authors:  S Z Wang; P G Hallsworth; K D Dowling; J H Alpers; J J Bowden; K D Forsyth
Journal:  Eur Respir J       Date:  2000-02       Impact factor: 16.671

Review 2.  IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family.

Authors:  C A Dinarello
Journal:  J Allergy Clin Immunol       Date:  1999-01       Impact factor: 10.793

Review 3.  Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu.

Authors:  K Nakanishi; T Yoshimoto; H Tsutsui; H Okamura
Journal:  Cytokine Growth Factor Rev       Date:  2001-03       Impact factor: 7.638

4.  Increased levels of circulating interleukin-18 in patients with advanced tuberculosis.

Authors:  G Yamada; N Shijubo; K Shigehara; H Okamura; M Kurimoto; S Abe
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

5.  Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing.

Authors:  S M van Schaik; D A Tristram; I S Nagpal; K M Hintz; R C Welliver; R C Welliver
Journal:  J Allergy Clin Immunol       Date:  1999-04       Impact factor: 10.793

6.  Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity.

Authors:  A H Brandenburg; A Kleinjan; B van Het Land; H A Moll; H H Timmerman; R L de Swart; H J Neijens; W Fokkens; A D Osterhaus
Journal:  J Med Virol       Date:  2000-10       Impact factor: 2.327

7.  Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis.

Authors:  L Bont; C J Heijnen; A Kavelaars; W M van Aalderen; F Brus; J T Draaisma; S M Geelen; H J van Vught; J L Kimpen
Journal:  Eur Respir J       Date:  1999-07       Impact factor: 16.671

8.  Peripheral blood eosinophil counts and eosinophil cationic protein content of respiratory secretions in bronchiolitis: relationship to severity of disease.

Authors:  R Garofalo; A Dorris; S Ahlstedt; R C Welliver
Journal:  Pediatr Allergy Immunol       Date:  1994-05       Impact factor: 6.377

9.  The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years.

Authors:  R C Welliver; L Duffy
Journal:  Pediatr Pulmonol       Date:  1993-01

10.  Respiratory viruses and exacerbations of asthma in adults.

Authors:  K G Nicholson; J Kent; D C Ireland
Journal:  BMJ       Date:  1993-10-16
View more
  14 in total

1.  Chronic PM2.5 exposure and risk of infant bronchiolitis and otitis media clinical encounters.

Authors:  Mariam S Girguis; Matthew J Strickland; Xuefei Hu; Yang Liu; Howard H Chang; Candice Belanoff; Scott M Bartell; Verónica M Vieira
Journal:  Int J Hyg Environ Health       Date:  2017-07-01       Impact factor: 5.840

2.  Concentrations of IL-15, IL-18, IFN-γ and activity of CD4+, CD8+ and NK cells at admission in children with viral bronchiolitis.

Authors:  Elżbieta Grześk; Sylwia Kołtan; Robert Dębski; Mariusz Wysocki; Marzena Gruszka; Małgorzata Kubicka; Andrzej Kołtan; Grzegorz Grześk; Sławomir Manysiak; Grażyna Odrowąż-Sypniewska
Journal:  Exp Ther Med       Date:  2010-07-20       Impact factor: 2.447

Review 3.  The role of Th17 and Treg responses in the pathogenesis of RSV infection.

Authors:  Thomas C Mangodt; Mikhaïl A Van Herck; Sara Nullens; José Ramet; Jozef J De Dooy; Philippe G Jorens; Benedicte Y De Winter
Journal:  Pediatr Res       Date:  2015-08-12       Impact factor: 3.756

Review 4.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

Review 5.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

6.  Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.

Authors:  Susana Chávez-Bueno; Asunción Mejías; Ana M Gómez; Kurt D Olsen; Ana M Ríos; Mónica Fonseca-Aten; Octavio Ramilo; Hasan S Jafri
Journal:  Virol J       Date:  2005-05-25       Impact factor: 4.099

7.  Peripheral immune cell markers in children with recurrent respiratory infections in the absence of primary immunodeficiency.

Authors:  Adriana Narcisa Munteanu; Mihaela Surcel; Radu-Ionuț Huică; Gheorghița Isvoranu; Carolina Constantin; Ioana Ruxandra Pîrvu; Carmen Chifiriuc; Coriolan Ulmeanu; Cornel Ursaciuc; Monica Neagu
Journal:  Exp Ther Med       Date:  2019-06-26       Impact factor: 2.447

8.  Age- and infection-related maturation of the nasal immune response in 0-2-year-old children.

Authors:  I J van Benten; C M van Drunen; L P Koopman; B C van Middelkoop; W C J Hop; A D M E Osterhaus; H J Neijens; W J Fokkens
Journal:  Allergy       Date:  2005-02       Impact factor: 13.146

9.  Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis.

Authors:  M F E Roe; D M Bloxham; D K White; R I Ross-Russell; R T C Tasker; D R O'Donnell
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

10.  Respiratory syncytial virus can infect basal cells and alter human airway epithelial differentiation.

Authors:  B David Persson; Aron B Jaffe; Rachel Fearns; Henry Danahay
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.